197 related articles for article (PubMed ID: 33611586)
21. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
22. Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.
Wamboga C; Matovu E; Bessell PR; Picado A; Biéler S; Ndung'u JM
PLoS One; 2017; 12(10):e0186429. PubMed ID: 29023573
[TBL] [Abstract][Full Text] [Related]
23. Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis (gHAT).
NTD Modelling Consortium Discussion Group on Gambiense Human African Trypanosomiasis
Gates Open Res; 2019; 3():1553. PubMed ID: 32411945
[TBL] [Abstract][Full Text] [Related]
24. Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC).
Castaño MS; Ndeffo-Mbah ML; Rock KS; Palmer C; Knock E; Mwamba Miaka E; Ndung'u JM; Torr S; Verlé P; Spencer SEF; Galvani A; Bever C; Keeling MJ; Chitnis N
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007976. PubMed ID: 31961872
[TBL] [Abstract][Full Text] [Related]
25. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
26. Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
Antillon M; Huang CI; Sutherland SA; Crump RE; Bessell PR; Shaw APM; Tirados I; Picado A; Biéler S; Brown PE; Solano P; Mbainda S; Darnas J; Wang-Steverding X; Crowley EH; Peka M; Tediosi F; Rock KS
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011396. PubMed ID: 37498938
[TBL] [Abstract][Full Text] [Related]
27. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
[TBL] [Abstract][Full Text] [Related]
28. Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.
Das AM; Chitnis N; Burri C; Paris DH; Patel S; Spencer SEF; Miaka EM; Castaño MS
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009992. PubMed ID: 34843475
[TBL] [Abstract][Full Text] [Related]
29. The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach.
Meisner J; Kato A; Lemerani MM; Mwamba Miaka E; Ismail Taban A; Wakefield J; Rowhani-Rahbar A; Pigott DM; Mayer JD; Rabinowitz PM
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010155. PubMed ID: 36037205
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19.
Hollingsworth TD; Mwinzi P; Vasconcelos A; de Vlas SJ
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):201-204. PubMed ID: 33693894
[No Abstract] [Full Text] [Related]
31. Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India.
Le Rutte EA; Coffeng LE; Muñoz J; de Vlas SJ
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):229-235. PubMed ID: 33580952
[TBL] [Abstract][Full Text] [Related]
32. Performance evaluation of a prototype rapid diagnostic test for combined detection of gambiense human African trypanosomiasis and malaria.
Lumbala C; Matovu E; Sendagire H; Kazibwe AJN; Likwela JL; Muhindo Mavoko H; Kayembe S; Lutumba P; Biéler S; Van Geertruyden JP; Ndung'u JM
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008168. PubMed ID: 32251426
[TBL] [Abstract][Full Text] [Related]
33. Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.
Simarro PP; Cecchi G; Franco JR; Paone M; Diarra A; Ruiz-Postigo JA; Mattioli RC; Jannin JG
Int J Health Geogr; 2014 Feb; 13():4. PubMed ID: 24517513
[TBL] [Abstract][Full Text] [Related]
34. Neglected tropical disease control in a world with COVID-19: an opportunity and a necessity for innovation.
Brooker SJ; Ziumbe K; Negussu N; Crowley S; Hammami M
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):205-207. PubMed ID: 33367883
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo.
Mumba D; Bohorquez E; Messina J; Kande V; Taylor SM; Tshefu AK; Muwonga J; Kashamuka MM; Emch M; Tidwell R; Büscher P; Meshnick SR
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1246. PubMed ID: 21829736
[TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo.
Rock KS; Torr SJ; Lumbala C; Keeling MJ
Parasit Vectors; 2015 Oct; 8():532. PubMed ID: 26490248
[TBL] [Abstract][Full Text] [Related]
37. Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?
Hasker E; Lutumba P; Chappuis F; Kande V; Potet J; De Weggheleire A; Kambo C; Depoortere E; Pécoul B; Boelaert M
PLoS Negl Trop Dis; 2012; 6(12):e1950. PubMed ID: 23272260
[No Abstract] [Full Text] [Related]
38. Data-driven models to predict the elimination of sleeping sickness in former Equateur province of DRC.
Rock KS; Pandey A; Ndeffo-Mbah ML; Atkins KE; Lumbala C; Galvani A; Keeling MJ
Epidemics; 2017 Mar; 18():101-112. PubMed ID: 28279451
[TBL] [Abstract][Full Text] [Related]
39. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
40. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.
Kura K; Ayabina D; Toor J; Hollingsworth TD; Anderson RM
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):236-244. PubMed ID: 33515038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
